Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients

DNA microarrays and RNA-based sequencing approaches are considered important discovery tools in clinical medicine. However, cross-platform reproducibility studies undertaken so far have highlighted that microarrays are not able to accurately measure gene expression, particularly when they are expres...

Full description

Bibliographic Details
Main Authors: Marina Martello, Vincenza Solli, Rosalinda Termini, Ajsi Kanapari, Daniel Remondini, Enrica Borsi, Andrea Poletti, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Gaia Mazzocchetti, Elena Zamagni, Alessandra Merlotti, Paola Tacchetti, Lucia Pantani, Serena Rocchi, Ilaria Rizzello, Katia Mancuso, Michele Cavo, Carolina Terragna
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/20/12450
_version_ 1797472753932042240
author Marina Martello
Vincenza Solli
Rosalinda Termini
Ajsi Kanapari
Daniel Remondini
Enrica Borsi
Andrea Poletti
Silvia Armuzzi
Barbara Taurisano
Ilaria Vigliotta
Gaia Mazzocchetti
Elena Zamagni
Alessandra Merlotti
Paola Tacchetti
Lucia Pantani
Serena Rocchi
Ilaria Rizzello
Katia Mancuso
Michele Cavo
Carolina Terragna
author_facet Marina Martello
Vincenza Solli
Rosalinda Termini
Ajsi Kanapari
Daniel Remondini
Enrica Borsi
Andrea Poletti
Silvia Armuzzi
Barbara Taurisano
Ilaria Vigliotta
Gaia Mazzocchetti
Elena Zamagni
Alessandra Merlotti
Paola Tacchetti
Lucia Pantani
Serena Rocchi
Ilaria Rizzello
Katia Mancuso
Michele Cavo
Carolina Terragna
author_sort Marina Martello
collection DOAJ
description DNA microarrays and RNA-based sequencing approaches are considered important discovery tools in clinical medicine. However, cross-platform reproducibility studies undertaken so far have highlighted that microarrays are not able to accurately measure gene expression, particularly when they are expressed at low levels. Here, we consider the employment of a digital PCR assay (ddPCR) to validate a gene signature previously identified by gene expression profile. This signature included ten Hedgehog (HH) pathways’ genes able to stratify multiple myeloma (MM) patients according to their self-renewal status. Results show that the designed assay is able to validate gene expression data, both in a retrospective as well as in a prospective cohort. In addition, the plasma cells’ differentiation status determined by ddPCR was further confirmed by other techniques, such as flow cytometry, allowing the identification of patients with immature plasma cells’ phenotype (i.e., expressing CD19+/CD81+ markers) upregulating HH genes, as compared to others, whose plasma cells lose the expression of these markers and were more differentiated. To our knowledge, this is the first technical report of gene expression data validation by ddPCR instead of classical qPCR. This approach permitted the identification of a Maturation Index through the integration of molecular and phenotypic data, able to possibly define upfront the differentiation status of MM patients that would be clinically relevant in the future.
first_indexed 2024-03-09T20:05:42Z
format Article
id doaj.art-4c9f08e932094267b251c9c92b513086
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T20:05:42Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-4c9f08e932094267b251c9c92b5130862023-11-24T00:31:54ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-10-0123201245010.3390/ijms232012450Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma PatientsMarina Martello0Vincenza Solli1Rosalinda Termini2Ajsi Kanapari3Daniel Remondini4Enrica Borsi5Andrea Poletti6Silvia Armuzzi7Barbara Taurisano8Ilaria Vigliotta9Gaia Mazzocchetti10Elena Zamagni11Alessandra Merlotti12Paola Tacchetti13Lucia Pantani14Serena Rocchi15Ilaria Rizzello16Katia Mancuso17Michele Cavo18Carolina Terragna19IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyClinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC Numbers CB16/12/00369, CB16/12/00489, 31001 Pamplona, SpainIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyDepartment of Physics and Astronomy, DIFA—University of Bologna, 40126 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyDepartment of Physics and Astronomy, DIFA—University of Bologna, 40126 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, 40138 Bologna, ItalyDNA microarrays and RNA-based sequencing approaches are considered important discovery tools in clinical medicine. However, cross-platform reproducibility studies undertaken so far have highlighted that microarrays are not able to accurately measure gene expression, particularly when they are expressed at low levels. Here, we consider the employment of a digital PCR assay (ddPCR) to validate a gene signature previously identified by gene expression profile. This signature included ten Hedgehog (HH) pathways’ genes able to stratify multiple myeloma (MM) patients according to their self-renewal status. Results show that the designed assay is able to validate gene expression data, both in a retrospective as well as in a prospective cohort. In addition, the plasma cells’ differentiation status determined by ddPCR was further confirmed by other techniques, such as flow cytometry, allowing the identification of patients with immature plasma cells’ phenotype (i.e., expressing CD19+/CD81+ markers) upregulating HH genes, as compared to others, whose plasma cells lose the expression of these markers and were more differentiated. To our knowledge, this is the first technical report of gene expression data validation by ddPCR instead of classical qPCR. This approach permitted the identification of a Maturation Index through the integration of molecular and phenotypic data, able to possibly define upfront the differentiation status of MM patients that would be clinically relevant in the future.https://www.mdpi.com/1422-0067/23/20/12450multiple myelomahedgehog signalingself-renewaldigital PCRplasma cell maturationdifferentiation stages
spellingShingle Marina Martello
Vincenza Solli
Rosalinda Termini
Ajsi Kanapari
Daniel Remondini
Enrica Borsi
Andrea Poletti
Silvia Armuzzi
Barbara Taurisano
Ilaria Vigliotta
Gaia Mazzocchetti
Elena Zamagni
Alessandra Merlotti
Paola Tacchetti
Lucia Pantani
Serena Rocchi
Ilaria Rizzello
Katia Mancuso
Michele Cavo
Carolina Terragna
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients
International Journal of Molecular Sciences
multiple myeloma
hedgehog signaling
self-renewal
digital PCR
plasma cell maturation
differentiation stages
title Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients
title_full Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients
title_fullStr Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients
title_full_unstemmed Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients
title_short Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients
title_sort identification of a maturation plasma cell index through a highly sensitive droplet digital pcr assay gene expression signature validation in newly diagnosed multiple myeloma patients
topic multiple myeloma
hedgehog signaling
self-renewal
digital PCR
plasma cell maturation
differentiation stages
url https://www.mdpi.com/1422-0067/23/20/12450
work_keys_str_mv AT marinamartello identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT vincenzasolli identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT rosalindatermini identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT ajsikanapari identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT danielremondini identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT enricaborsi identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT andreapoletti identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT silviaarmuzzi identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT barbarataurisano identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT ilariavigliotta identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT gaiamazzocchetti identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT elenazamagni identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT alessandramerlotti identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT paolatacchetti identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT luciapantani identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT serenarocchi identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT ilariarizzello identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT katiamancuso identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT michelecavo identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients
AT carolinaterragna identificationofamaturationplasmacellindexthroughahighlysensitivedropletdigitalpcrassaygeneexpressionsignaturevalidationinnewlydiagnosedmultiplemyelomapatients